000 02828cam a2200349 a 4500
003 EG-GiCUC
005 20250223031503.0
008 160507s2015 ua o f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.09.08.M.Sc.2015.Wa.E
100 0 _aWaddah Mohammed Nasouh Aljunidi
245 1 4 _aThe effect of non-surgical periodontal therapy on visfatin level in gingival crevicular fluid in patients with chronicperiodontitis /
_cWaddah Mohammed Nasouh Aljunidi ; Supervised Azza Ezz Elarab , Olfat Shaker , Eman Amr
246 1 5 _aتأثير علاج اللثة غير الجراحى على مستوى الفسفاتين فى السائل اللثوى لدى مرضى التهاب اللثة المزمن
260 _aCairo :
_bWaddah Mohammed Nasouh Aljunidi ,
_c2015
300 _a74 P. :
_bphotographs ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Oral and Dental Medicine - Department of Periodontology
520 _aThe aim of this study was to investigate the effect of non surgical periodontal therapy on GCF level of Visfatin in patients with moderate chronic periodontitis. The purpose of the present study was to assess the level of visfatin in samples of GCF from chronic periodontitis patients before and after scaling and root planing (SRP).The study included 30 patients divided into two groups: Group I: consisted 20 patients with chronic periodontitis treated by scaling and root planing.Group II: the control group which consisted of ten healthy individuals.Clinical parameters including gingival index, plaque index, pocket depth and clinical attachment level were measured and GCF samples were collected using paper points for each patient at baseline for both groups and 4 weeks after treatment by (SRP) for group I only. Visfatin detection in GCF was performed using a commercial ELISA kit. The results of the present study revealed that the highest levels of Visfatin concentrations in GCF were obtained in chronic periodontitis group I and the least levels were found in the control group II with a statistically significant difference between them. Visfatin levels in GCF decreased in chronic periodontitis group after treatment, yet it's level was still higher than that of the control group. Visfatincould be used as a marker for the periodontal disease activity and outcome of periodontal therapy
530 _aIssued also as CD
653 4 _aChronic periodontitis
653 4 _aPeriodontitis
653 4 _aVisfatin
700 0 _aAzza Ezz Elarab ,
_eSupervisor
700 0 _aEman Amr ,
_eSupervisor
700 0 _aOlfat Shaker ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c56304
_d56304